Protheragen Will Attend 2023 SAPA-GP Annual Conference- 大数跨境

首页

Protheragen Will Attend 2023 SAPA-GP Annual Conference

Protheragen

2023-03-29

导读：Meet us in person on March 31 to April 1.

参会邀请

美中医药协会-大费城分会（SAPA-GP）将于美东时间2023年3月31-4月1日举办一年一度的协会年会。此次年会采用线下会形式，聚集多位生物医药领域的科技人才、商界精英、企业代表。

作为赞助商之一，Protheragen Inc. 十分期待聆听来自各位科学家、企业高管、机构代表关于生物医药2.0的独特见解，同时也欢迎各位业界精英到我们的摊位上沟通交流，探寻商业合作、职业发展的机会。

会议信息

会议主题：

Biopharma 2.0:

Embracing New Technologies in a Changing World

会议时间：

美东时间3月31日: 1:00 pm - 9:00 pm

美东时间4月1日: 8:30 am - 5:00 pm

会议地点：

Sheraton Valley Forge Hotel

480 N Gulph Rd, King of Prussia, PA 19406

会议概况：

5大论题：科学、临床、商业、市场研究、职业发展
26 场主题会议精彩纷呈
68 位生物医药界精英倾囊演讲

会议日程

星期五	March 31, 2023
12:30-13:00	Check in
Plenary Session @ Grand Ballroom
13:00-13:15	Opening Remarks & Welcome
13:15-14:00	Transmission of Misfolded Proteins in Neurodegenerative Disorders
14:00-14:45	M&A Transactions Across the Pharmaceutical Industry
14:45-15:15	Coffee Break
Drug Discovery and Development @ Grand Ballroom
Session 1: Revolutionary Nonclinical Approaches: Reducing Animal Use and Developing Alternative Models
15:15-15:45	‘A New Age’ for Reduction of Non-Human Primate Use in Drug Development
15:45-16:15	Next Generation Non-animal Testing Models for Early Pre-clinical Drug Screening and Discovery
16:15-16:45	From AI Database Mining to the Identification of Therapeutic Target for Metabolic Disorders
Clinical Development and Regulatory @ Centennial Ballroom II
Session 1: New Trends in Clinical Trials
15:15-15:45	Faster, More Inclusive, Patient-Friendly Clinical Research
15:45-16:15	Medidata AI: Data Driven Approaches to Improving the Probability of Technical and Regulatory Success (PTRS)
16:15-16:45	Quantitative Landscape Database Building and Modeling to Enhance Drug Development Probability of Success
Business Development @ Centennial Ballroom I
Session 1: The Guide to Succeed in Business Development Despite IRA, Drying Capital, and Furious US/China Competition
15:15-16:00	The current Trends of the Global BD Trends in Therapeutics, with a Focus on the US/China Deal-making, and More
15:15-16:00	The Legal Considerations when Conducting BD in the US, Especially for Foreign Companies
15:15-16:00	Recent Inspirative BD Cases Bridging across the Border
16:00-16:45	Panel Discussion
Frazer: Promoting Patient Access Using Real-World Evidence
Session 1: Health Economics and Outcomes Research
15:15-15:45	Health Economic and Outcome Research for Product Development
15:45-16:15	Social Value of Medicines: A Critical Element in Value Assessment
Ardmore: Career Development Round Table Discussion
15:15-16:45	Marketing Yourself
16:45 - 18:00 Reception&Networking @ Grand Ballroom
18:00 - 21:00 Dinner (with tickets) @ Grand Ballroom
18:00-18:15	President Speech
18:15-18:35	SAPA-GP Song Li Scholarship Ceremony
星期六	April 1, 2023
8:30-8:45	Check in
Welcome, President-Elect Announcement & Speech @ Grand Ballroom, 08:45-09:00
9:00-9:45	Decentralized Clinical Trials and DTRA: What Are They Exactly and What Dose the Future Look Like.
9:45-10:30	Model Informed Drug Development – Approaches in Lifecycle Drug Development and Regulatory Decision Making
10:30-10:50	Coffee Break
10:50 - 12:20 Parallel Sessions
Drug Discovery and Development @ Grand Ballroom
Session 2: Enabling Patient Centric Formulation Biologics Design by Pushing the Limit of Protein Concentration
10:50-11:20	Patient Centric Biologics Development (Tentative)
11:20-11:50	Acceleration of Formulation and Process Development
11:50-12:20	Different Models to Predict Human Bioavailability of Subcutaneously Administered Monoclonal Antibodies at Preclinical and Clinical Stages
Clinical Development and Regulatory @ Centennial Ballroom II
Session 2: Best Practice of Co-development of Drug and Companion Diagnostics (CDx)
10:50-11:20	Technical and Practical Aspects of an CDx Assay from Concept Design to Marketing Application
11:20-11:50	Current Regulatory Requirements of Biomarkers in Oncology Drug Development
11:50-12:20	Setting Companion Diagnostics Strategy for Precision Medicine in Cncology – Perspectives from Biotech
Business Development @ Centennial Ballroom I
Investment Winter – Alternative Strategy
10:50-11:20	Alternative Financing Options for Biotech
11:20-11:50	Lining up Business Plan Milestones with the Size of the Raise
11:50-12:20	From Idea to Product Launch: a Journey in Biotech Entrepreneurship and Fundraising
Promoting Patient Access Using Real-World Evidence
Session 2: Real World Data (RWD) and Real World Evidence (RWE)
10:50-11:20	“What if” AI with Real-world Data from Prediction to Intervention Modeling to Fairness and Disparities
11:20-11:50	RWD/RWE: To Replicate Or Continue To Learn In The Real World?
11:50-12:20	Effectiveness of COVID-19 Vaccines in Children and Adolescents: Findings from Trial Emulation using an EHR-Based Cohort from the RECOVER Program
Career Development Round Table Discussion
10:50-12:20	Effective Communication in Workplace
12:20 - 13:30 Lunch Break Networking & Lunchtime Sessions
13:30 - 14:30 Parallel Sessions
Drug Discovery and Development @ Grand Ballroom
Session 3: New Platform to Support Drug Discovery
13:30-14:00	Characterizing ADME Properties of Oligonucleotide Therapeutics
14:00-14:30	Large-scale Characterization of Drug Candidates Against Transmembrane Receptors using HT-SPR
14:30-15:00	Harnessing the Power of the Human Memory B Cell
Clinical Development and Regulatory @ Centennial Ballroom II
Session 3: Model Informed Drug Development (MIDD) - Approaches in Lifecycle Drug Development and Regulatory Decision Making
13:30-14:00	Model Informed Drug Development in Oncology: Clinical Pharmacology Perspectives
14:00-14:30	Physiologically Based Pharmacokinetic (PBPK) in Life Cycle Management and Regulatory Submissions
14:30-15:00	Quantitative Systems Pharmacology (QSP) to Improve Hypothesis Generation in Pharmaceutical Drug Discovery and Development
Business Development @ Grand Ballroom
Session 3: Product Launch and Commercialization
13:30-14:00	Commercializing Rare Disease Treatments: Key Challenges and How Ambit is Helping Companies Transform their Approach with Data and Analytics
14:00-14:30	Key Considerations and Strategies for Commercializing Cell Therapies in China
14:30-15:00	Market Access – What, Why, When, and How
Frazer: Biopharma Compensation and Labor Law New Trends
13:45-14:15	Latest Update in Labor Law and Employee Rights
14:15-14:45	The IPO Process and Employee Stock Options
14:45-15:10	Q&A
Ardmore: Career Development Roundtable
13:30-15:00	Transferrable Skill
15:00-15:20	Coffee Break
15:20 - 16:50 Parallel Sessions
Drug Discovery and Development @ Grand Ballroom
Session 4: Discovery of Drug Targets with Novel Mechanisms
15:20-15:50	The Role of PRMT5 in Vascular Remodeling
15:50-16:20	AUTS2 and Neuronal Differentiation: Modeling and Mechanistic Characterization of Neurodevelopmental Disorders in Vitro.
16:20-16:50	Target and Modality Selection For Treating CNS Diseases
Clinical Development and Regulatory @ Centennial Ballroom II
Session 4: Data Science in Accelerating Clinical Development
15:20-15:45	Qualification Journey of Digital Biomarkers as Primary Endpoint
15:45-16:10	Opportunities and Challenges of Applying ML and AI for Precision Oncology
16:10-16:35	Data-driven RSV Disease Forecasting to Facilitate Large Clinical Trial Operation Excellence
16:25-17:00	Digital Endpoints That Matter to Patients
Diversity & Inclusion @ Centennial Ballroom I
15:20-16:50	Diversity, Equity and Inclusion: Awareness, Advocate and Action!
Ardmore: Career Development Roundtable
15:20-16:50	The Pharmaceutical Industry: What You Need to Know
Frazer: Company Showcase
15:20-15:50	The Biomarker Oriented Preclinical Study in the Era of Cell& Gene Therapy
17:00 - 17:20 Closing Remarks & Volunteer Awards @ Grand Ballroom
17:20 - 18:00 Reception & Networking